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endoprostheses are mentally and physically wearing for the patient,
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challenging for the surgeon and a significant economic burden for
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inplaceiswidelyaccepted.Therecommendationsforthemanagement
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over 90% of all cases for certain patient collectives. But implant associ-
ated infection still remains a severe complication. Moreover, the man-
agement of late endoprosthetic infection requires specific logistics,
sufficient and standardized treatment protocol, qualified manpower as
well as an efficient quality management. With regard to the literature
and experience of specialized orthopaedic surgeons from several uni-
versity and regional hospitals we modified a commonly used treatment
protocol for two-stage revision of infected total hip and knee endopros-
theses. In addition to the achievement of maximum survival rate of the
revision implants an optimisation of the functional outcome of the af-




Bei Revisionseingriffen wächst der Anteil der Behandlung septisch be-
dingter Lockerungen von Hüft- und Knie-Endoprothesen. Für den Pati-
enten stellt die Revisionsoperation infizierter Endoprothesen eine
mentale und physische Belastung dar, für den Chirurgen sind sie eine
Herausforderung und für das Gesundheitssystem eine beträchtliche
wirtschaftliche Belastung. Bei der Frühinfektion innerhalb der ersten
drei Wochen nach Implantation ist eine einzeitige Revision, bei der das
Implantat im Körper verbleibt, weithin akzeptiert. Dagegen gehen die
Empfehlungen für das Management von Spätinfekten deutlich ausein-
ander. Sowohl bei einzeitigen als auch bei zwei- oder mehrzeitigen Im-
plantatwechseln wird von Erfolgsraten von über 90% für bestimmte
Patientengruppen berichtet. Dennoch zählen Implantat-assoziierte In-
fektionen weiterhin zu den schweren Komplikationen. Zudem erfordert
das Management von Spätinfekten eine besondere Logistik, angemes-
seneundstandardisierteBehandlungsvorgaben,qualifiziertesPersonal





und Knie-Endototalprothesen modifiziert. Neben dem Erreichen einer
1/8 GMS Krankenhaushygiene Interdisziplinär 2011, Vol. 6(1), ISSN 1863-5245
Research Article OPEN ACCESSmaximalen Standzeit der Revisionsimplantate besteht das Ziel darin,
dasFunktionsniveauderbetroffenenkünstlichenGelenkezuverbessern.




total knee arthroplasties are performed annually in Ger-
many [1], [2]. Periprosthetic infections are described to
occur in only 1% of all primary hip arthroplasties [3]. But
in patients with existing risk factors such as diabetes,
rheumatoid arthritis or after aseptic revision the risk of
a late infection escalates up to >5% [4], [5], [6]. Due to
the demographic changes implant-associated infections
will gain increasing importance for patients, orthopaedic
surgeonsandhealthcaresystems.Asaresult,deepinfec-
tion has taken over the second place of reasons for reop-
eration (25.9% of all reoperations) within the first two
years after implantation [7]. The mean annual economic
revision burden of total hip and knee arthroplasties has
reached up to 20% [8]. Complicated septic revisions
caused costs of 50,000 Euro or even more [9]. Hence,
the clinical and economic impact of implant-associated
infections after total hip and knee arthroplasty must be
expected to gain significance in the future.
The period for grading an implant-related infection as
“early infection” ranges from 3 weeks to 3 month post-
operatively in literature [10], [11], [12]. Over the last few
years there is a clear tendency to limit “early infections”
to the first 3 to 4 weeks postoperatively because of a
more profound knowledge of the pathophysiology of in-
fectionandtheresponsiblemicroorganisms.Whetheran
early or late periprosthetic infection does occur this has





should be performed since bacterial biofilms are found
on these implants [14].
As opposed to this, the question how “late infections”
should be treated is still undecided and lively discussed
in the literature [3], [10], [12], [15], [16], [17], [18]. But
thereisaconsensusthatbasicallyatreatmentalgorithm
should be established for medical, economical and
forensicreasons[16].Besidesthefactthatthetreatment
needs to be standardized, this must hold true for the
diagnostics of periprosthetic infections. Especially in
cases of low-grade infections, infections with biofilm-
producingbacteriaorsmallcolonyvariantsandpreceding
antibiotic therapy, the classical diagnostic procedures
(e.g. preoperative joint fluid aspiration, intraoperative
swabs) are insufficient [10], [19], [20].
With regard to the literature and the experience of spe-
cializedorthopaedicsurgeonsfromseveraluniversityand
regional hospitals we modified a commonly used treat-
ment protocol [12]. A common concept allows to merge
outcome data and to share expensive resources (e.g.
laboratories, staff training, materials). Moreover, the
presented algorithm is the basis for a prospective follow-
up study which is especially focussed on infections with
multi-resistant bacteria and treatment with improved
temporary spacers.
Diagnostic and Treatment Protocol
A periprosthetic infection is assured if clinical signs such
asafistulaorpurulentwoundsecretionoccur.Otherwise
wecombinetheinformationfromtheclinicalexamination,
laboratory (white blood cell count (WBC), C-reactive pro-
tein (CrP) and erythrocyte sedimentation rate (ESR)), ra-
diographs(osteolyses)andamini-incisionbiopsy(aspirate
tissue for microbiological/histological examination) to
identify periprosthetic infections according to Maurer et
al. [17] and Laffer et al. [21]. After diagnosing a peripros-
thetic infection the further treatment is carried out with
respect to following therapy algorithm (Figure 1).
Early infection
In case of an early infection without risk factors at least
thepolyethylenecomponent(hip,knee)andfemoralhead
(hip) should be changed to enable cleaning of the metal-
back surfaces by antiseptics (e.g. Octenisept
®, Schülke
und Mayr GmbH, Norderstedt, Germany) and pulsatile
lavage.Acompleteone-stageexchangeisindicatedwhen
risk factors are present (Table 1, Table 2). From our point
ofviewimplantloosening,significantsoft-tissuedamage,
and complicated-to-treat bacterial colonization as “abso-
lute” are certain risk factors meaning that each of them




staging system [11], [22], [23]. Since these factors are
known to impair wound healing and to encourage peri-
prosthetic infections we rate them as “relative” factors.
Inabsenceofany“absolute”riskfactorstheorthopaedic
surgeonshouldassesstheindividual“relative”riskprofile
of the patient in order to decide whether a partial or
complete exchange is preferable. With multiple and/or
very severe “relative” risk factors (local and systemic)
even a two-stage exchange may be considered. If a ce-
mented component fixation is necessary, antibiotics
should be added to the cement adapted to the microbio-
logical results. Even in case of negative or missing previ-
ous microbiological status the use of revision cement
containingcertainantibiotics(e.g.gentamycin,vancomy-
cin and clindamycin) is recommended.
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Table 1: Risk factors for endoprosthesis-related infections
Table 2: Relative risk factors for endoprosthesis-related infections according to Cierny-Mader [22, 23].
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operation including the explantation of the total hip/knee endoprosthesis
Moreover, any one-stage revision should include an ex-
change of gloves, instruments and sterile covering after
pulsatile lavage. Tissue samples for microbiological and
histological analyses are obtained intraoperatively in a
standardized manner (Table 3) in order to adapt the
postoperativedoubleantibiotictreatment.Withoutclinic-
al, histological and microbiological sign of an infection
after revision surgery i.v. antibiotics are administered for




risk factors a complete one-stage exchange is justified
(Figure 1). Otherwise we conduct a two-stage revision
with a 6 weeks temporary spacer interval (Figure 2).
Handmade or ready-made antibiotic loaded cement
spacers are widely accepted. Hip stems with an antimi-
crobial TiCuN-coating can also be used for selected pa-
tients. Regardless of the chosen type of spacer it must
maintain the length of the soft-tissue and stabilize the
affected joint. Application of an external orthosis may
provide additional joint stability. Tissue samples for mi-
crobiologicalandhistologicalanalysesareobtainedintra-
operatively (Table 3). The explanted endoprosthetic im-
plants are additionally analyzed by a sonification culture
in case of low-grade infection or negative previous micro-
biology despite clear infection signs according to Maurer
et al. [17]. The double antibiotic treatment is adapted to
the antibiogram and administered for 4 weeks (2 weeks
i.v., 2 weeks p.o.).
Joint fluid (cytology) and tissue samples (microbiology,
histology) are obtained 6 weeks postoperatively. After 2
weeks incubation the results are evaluated along with
the clinical and laboratory findings. Especially the ESR
and CrP should not be significantly elevated.
If there are no signs of infection, 8 weeks after implant
removal the revision endoprosthesis can be implanted
accompanied by antibiotic treatment for 2 weeks (intra-
operativemicrobiologynegativeor4weeks(intraoperative
microbiology positive). Thereby multiple samples (two for
microbiology and one for pathology) are taken from the
periarticular tissue and intramedullary space. Otherwise
in case of any signs of infection the antibiotic treatment
is prolonged from two to four weeks.
In case of persisting signs of infection 8 weeks after im-
plantation of the spacer, a revision operation including
debridementandspacerexchangeisindicated(Figure2).
Tissue samples are taken in a standardized manner
(Table 3) to acquire a full-field analysis of the present
microbiological colonization. After 2 weeks it must be
decidedwhetherre-implantationispossibleoranindividu-
al concept is needed for the patient.
Discussion
In case of a necessary revision surgery of total joint
arthroplasty it is crucial to distinguish between aseptic
or septic revision because treatment is completely differ-
ent.Thediagnosis“periprostheticinfection”maybeclear
when purulent secretion and signs of septicaemia are
apparent. But in cases of suspected septic loosening the
preoperative laboratory and puncture fail to identify bac-
terial colonization in up to 20% of all cases [15], [20],
[24], [25]. A mini-incision biopsy (e.g. automatic needle)
obtaining tissue for a permanent histology is recommen-
ded to increase diagnostic sensitivity [26]. Particularly
the microorganisms causing low-grade infections could
be failed to identify by culture [27]. Aiming to acquire the
complete spectrum of microorganism causing septic
loosening especially for biofilm-producing bacteria or in
case of previous antibiotic treatment sonification and
16SPCRofexplanteddeviceshavetobeconducted.PCR
and culturing the sonification fluid is likely to raise sens-
itivity of cultures significantly, but possibly wrong-positive
results have to be critically evaluated [28], [29], [30].
The treatment of periprosthetic infections is undisputed
incaseofperacuterespectivelyhigh-gradeinfection[31].
Anurgentrevisionsurgerywithevacuationofpusisindic-
ated. After gaining the tissue samples a calculated anti-
biotic therapy is initiated and should be adapted after
receiving the microbiological results. Septic or multimor-
bid patients may need a two-stage explantation. Loose
and easy removable implant parts as well as necrotic
tissue are removed within the first operation, remaining
cement or well-integrated implant parts are explanted
after non-surgical stabilization of the patient.
In patients with early infection a one-stage procedure is
widely accepted [6], [10], [12], [13]. Since most patients
with an early infection lack significant risk factors due to
the directly preceding arthroplasty, a one-stage partial
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exchange is sufficient. Some authors recommend a neg-
ative pressure therapy (NPT) (V.A.C.
®, KCI Wiesbaden,
Germany)combinedwithasuction/irrigationsystem[32],
[33]. But due to the limited success rates of 50% to 60%
[15], [32] the vacuum assisted closure therapy remains
an option for isolated cases [13], [34].
But how patients with non-fulminant periprosthetic late
infection should be treated is still discussed in literature
controversially. One-stage as well as two-stage revisions
have been reported to be successful in 80% to 100% [3],
[15], [18], [35], [36]. One-stage concepts are described
to be advantageous concerning duration of hospitaliza-
tion, functional outcome, and economic aspects [15],
[18], [24], [37]. But most of the proponents retract from
their one-stage concept, whenever the bacterial coloniz-
ationisunclearornoteasytotreat,thepatient`sgeneral
condition is reduced, soft-tissue is compromised or if the
patient had multiple previous operations [3], [15], [18],
[37].Thoughthisleadstoaselectionofpatients,DeMan
et al. compared 22 patients after one-stage exchange to
50 patients after two-stage exchange. Although the one-
stage patients had better prerequisites, the clinical
(Harris hip score) and radiological outcome did not differ
after2yearsbetweenthetwogroups[18].Sincethevast
5/8 GMS Krankenhaushygiene Interdisziplinär 2011, Vol. 6(1), ISSN 1863-5245
Ellenrieder et al.: Two-stage revision of implant-associated infections ...majorityofthepatientsmeettheriskfactorsgivenabove,
we agree that in case of late infections the two-stage re-
vision is still the “gold standard” [3], [4], [10], [12], [13],
[38]. A complete removal of the colonized implants and
athoroughdebridementofinfectedtissueisthecommon
basis for both concepts.
Therecommendedspacerintervalvariesmarkedlyinthe
literature from 3 weeks to >1 year, most common are
6–12 weeks [3], [10], [17]. Our two-stage protocol is
basedonan8weekintervalprovidinga2weekantibiotic-
free period before obtaining tissue samples. Due to pos-
sible residual effects of systemic and local antibiotics
tissue samples are proven to increase the diagnostic
sensitivity for persisting infection [20], [39], [40], [41].
As standard spacers we are using antibiotic loaded ce-
ment spacers for the knee and hip as well as TiCuN
coatedspacers(hip)forselectedcases.However,cement
spacers, especially articulating spacers, are suspected
to produce wear debris leading to higher wear rates of
therevisionimplant[3].Asanalternative,cementwithout





The reimplantation is performed 8 weeks after septic
explantation if the preoperatively obtained tissue shows
no microbiological or histological signs of infection. Fur-
thermore,noclinical/laboratoryinfectionsignsareappar-
ent(Figure2).Hencethevalidityoflaboratoryparameters
for diagnosing a periprosthetic infection is not entirely
clarified so far [20], [45], [46], [47], [48], [49]. In partic-
ular, the ESR and CRP should be within normal range or
is only slightly elevated (e.g. CRP ≤12 mg/L) [48]. The
type of revision endoprosthesis (length, modularity, con-
strained knee, cemented/cementless fixation) depends
on the quality of the bone, the type of bone defect and
the condition of soft tissue structures. For cemented im-
plants the antibiotics added to the bone cement can be
adapted to the sensitivity of the bacteria [15], [17], [18].
In case of persisting infection another kind of revision
surgery is indicated (Figure 2) [9], [13], [17]. Patients
with not controllable infection that are multimorbid, lim-
ited operable or have a short life expectancy may need
an individual concept. Alternative treatment options
comprise Girdlestone hip, knee arthrodesis, permanent
fistula or amputation as a last resort [9], [15], [50].
Conclusions
Treatmentofimplant-associatedinfectionsaftertotalhip
and knee arthroplasty requires an experienced hospital
staff and appropriate facilities (e.g. operation rooms,
isolation sick chambers, intensive care unit). Moreover
a wide spectrum of diagnostic (e.g. microbiology, patho-
logy,radiology,nuclearmedicine)andtherapeuticpossib-
ilities (multidisciplinary physician team, individual im-
plants, psychological support) should be provided. A
treatment algorithm makes the necessary steps and de-
cisionpathwaysmorecomprehensibleforthepatientand
new staff. The presented algorithm has been thoroughly
refined with regard to the literature and the experience
of specialized orthopaedic surgeons from several univer-
sity and regional hospitals in Mecklenburg-Pomerania,
Germany.Standardizeddocuments(e.g.patientinforma-
tionsheet,studyagreement)shouldavoidtolooseimport-
ant information (e.g. “mismatch” of implants, individual
concepts, recurrence of infection) from the therapeutic
and forensic aspect. A quality management system can
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